Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
2,636
Views
5
CrossRef citations to date
0
Altmetric
Cardiovascular
Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention
William A. Graya Division of Cardiovascular Diseases, Lankenau Heart Institute, Philadelphia, PA, USACorrespondence[email protected]
https://orcid.org/0000-0003-4676-2839
Robert I. Griffithsb Boston Scientific, Marlborough, MA, USA
, Peter W. M. Elroyc BresMed Health Solutions, Sheffield, UK
, Stacey L. Amorosib Boston Scientific, Marlborough, MA, USA
, Alysha M. McGovernb Boston Scientific, Marlborough, MA, USA
https://orcid.org/0000-0002-6486-1788
Michael R. Jaffb Boston Scientific, Marlborough, MA, USA
https://orcid.org/0000-0002-3772-5887
Ron Akehurstc BresMed Health Solutions, Sheffield, UK;d School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK
& Stefan Müller-Hülsbecke Diaconess Hospital Flensburg, Flensburg, Germany
https://orcid.org/0000-0001-6011-9466
Pages 880-887
|
Received 31 Mar 2022, Accepted 09 Jun 2022, Published online: 28 Jun 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.